JVATiTD - Articles

Official publication of CEVAP/UNESP

Snake venom disintegrins update: insights about new findings

Gabriela de Oliveira Almeida1, Isadora Sousa de Oliveira2,3, Eliane Candiani Arantes2, and Suely Vilela Sampaio1* [ + show more ]

J Venom Anim Toxins incl Trop Dis, 2023, 29:e20230039
Received: 17 June 2023 | Accepted: 25 August 2023 | Published online: 18 September 2023


Snake venom disintegrins are low molecular weight, non-enzymatic proteins rich in cysteine, present in the venom of snakes from the families Viperidae, Crotalidae, Atractaspididae, Elapidae, and Colubridae. This family of proteins originated in venom through the proteolytic processing of metalloproteinases (SVMPs), which, in turn, evolved from a gene encoding an A Disintegrin And Metalloprotease (ADAM) molecule. Disintegrins have a recognition motif for integrins in their structure, allowing interaction with these transmembrane adhesion receptors and preventing their binding to proteins in the extracellular matrix and other cells. This interaction gives disintegrins their wide range of biological functions, including inhibition of platelet aggregation and antitumor activity. As a result, many studies have been conducted in an attempt to use these natural compounds as a basis for developing therapies for the treatment of various diseases. Furthermore, the FDA has approved Tirofiban and Eptifibatide as antiplatelet compounds, and they are synthesized from the structure of echistatin and barbourin, respectively. In this review, we discuss some of the main functional and structural characteristics of this class of proteins and their potential for therapeutic use.

Full Article PDF